Given that the effects of metformin on cognition and AD-related pathologies remain to be determined, we investigated whether metformin could prevent the propagation of Aβ and tau pathology in PS19BE-injected APP/PS1 mice. This evidence concerns the gene MAPT and Alzheimer disease.